Does Low-dose Aspirin prevent preeclampsia or merely delay it?

Area of Science:

• Obstetrics and Gynecology
• Perinatal Medicine
• Pharmacology in Pregnancy

Background:

• Low-dose aspirin (LDA) is widely used for preventing preeclampsia.
• Current evidence shows a modest overall reduction in preeclampsia rates with LDA.

Purpose of the Study:

• To investigate the specific impact of LDA on early-onset preeclampsia (EOPE).
• To explore whether different phenotypes of preeclampsia respond differently to aspirin therapy.

Main Methods:

• Analysis of clinical data on preeclampsia incidence and timing.
• Comparative assessment of LDA's effect on early-onset versus late-onset preeclampsia.

Main Results:

• LDA's primary benefit appears to be delaying the onset of preeclampsia before 34 weeks gestation.
• This suggests distinct pathophysiological pathways for early-onset and term preeclampsia, with differential responses to aspirin.

Conclusions:

• LDA may be particularly effective in preventing early-onset preeclampsia (EOPE).
• Preventing EOPE, which causes significant maternal and neonatal morbidity/mortality, offers substantial long-term benefits.
• Targeted use of LDA may be crucial for mitigating the most severe pregnancy complications.